The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range"
Michaela Kotrova1, Eva Fronkova2, Michael Svaton2,3,4
1Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.
Leukemia
|May 17, 2024
Abstract
No abstract available in PubMed .
More Related Videos
08:37Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control
Published on: March 30, 2015
13.6K
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
400
